

Currently released so far... 51122 / 251,287
Articles
Brazil
Sri Lanka
United Kingdom
Sweden
00. Editorial
United States
Latin America
Egypt
Jordan
Yemen
Thailand
Browse latest releases
2010/12/01
2010/12/02
2010/12/03
2010/12/04
2010/12/05
2010/12/06
2010/12/07
2010/12/08
2010/12/09
2010/12/10
2010/12/11
2010/12/12
2010/12/13
2010/12/14
2010/12/15
2010/12/16
2010/12/17
2010/12/18
2010/12/19
2010/12/20
2010/12/21
2010/12/22
2010/12/23
2010/12/24
2010/12/25
2010/12/26
2010/12/27
2010/12/28
2010/12/29
2010/12/30
2011/01/01
2011/01/02
2011/01/04
2011/01/05
2011/01/07
2011/01/09
2011/01/11
2011/01/12
2011/01/13
2011/01/14
2011/01/15
2011/01/16
2011/01/17
2011/01/18
2011/01/19
2011/01/20
2011/01/21
2011/01/22
2011/01/23
2011/01/24
2011/01/25
2011/01/26
2011/01/27
2011/01/28
2011/01/29
2011/01/30
2011/01/31
2011/02/01
2011/02/02
2011/02/03
2011/02/04
2011/02/05
2011/02/06
2011/02/07
2011/02/08
2011/02/09
2011/02/10
2011/02/11
2011/02/12
2011/02/13
2011/02/14
2011/02/15
2011/02/16
2011/02/17
2011/02/18
2011/02/19
2011/02/20
2011/02/21
2011/02/22
2011/02/23
2011/02/24
2011/02/25
2011/02/26
2011/02/27
2011/02/28
2011/03/01
2011/03/02
2011/03/03
2011/03/04
2011/03/05
2011/03/06
2011/03/07
2011/03/08
2011/03/09
2011/03/10
2011/03/11
2011/03/13
2011/03/14
2011/03/15
2011/03/16
2011/03/17
2011/03/18
2011/03/19
2011/03/20
2011/03/21
2011/03/22
2011/03/23
2011/03/24
2011/03/25
2011/03/26
2011/03/27
2011/03/28
2011/03/29
2011/03/30
2011/03/31
2011/04/01
2011/04/02
2011/04/03
2011/04/04
2011/04/05
2011/04/06
2011/04/07
2011/04/08
2011/04/09
2011/04/10
2011/04/11
2011/04/12
2011/04/13
2011/04/14
2011/04/15
2011/04/16
2011/04/17
2011/04/18
2011/04/19
2011/04/20
2011/04/21
2011/04/22
2011/04/23
2011/04/24
2011/04/25
2011/04/26
2011/04/27
2011/04/28
2011/04/29
2011/04/30
2011/05/01
2011/05/02
2011/05/03
2011/05/04
2011/05/05
2011/05/06
2011/05/07
2011/05/08
2011/05/09
2011/05/10
2011/05/11
2011/05/12
2011/05/13
2011/05/14
2011/05/15
2011/05/16
2011/05/17
2011/05/18
2011/05/19
2011/05/20
2011/05/21
2011/05/22
2011/05/23
2011/05/24
2011/05/25
2011/05/26
2011/05/27
2011/05/28
2011/05/29
2011/05/30
2011/05/31
2011/06/01
2011/06/02
2011/06/03
2011/06/04
2011/06/05
2011/06/06
2011/06/07
2011/06/08
2011/06/09
2011/06/10
2011/06/11
2011/06/12
2011/06/13
2011/06/14
2011/06/15
2011/06/16
2011/06/17
2011/06/18
2011/06/19
2011/06/20
2011/06/21
2011/06/22
2011/06/23
2011/06/24
2011/06/25
2011/06/26
2011/06/27
2011/06/28
2011/06/29
2011/06/30
2011/07/01
2011/07/02
2011/07/04
2011/07/05
2011/07/06
2011/07/07
2011/07/08
2011/07/10
2011/07/11
2011/07/12
2011/07/13
2011/07/14
2011/07/15
2011/07/16
2011/07/17
2011/07/18
2011/07/19
2011/07/20
2011/07/21
2011/07/22
2011/07/23
2011/07/25
2011/07/27
2011/07/28
2011/07/29
2011/07/31
2011/08/01
2011/08/02
2011/08/03
2011/08/05
2011/08/06
2011/08/07
2011/08/08
2011/08/09
2011/08/10
2011/08/11
2011/08/12
2011/08/13
2011/08/15
2011/08/16
2011/08/17
2011/08/18
2011/08/19
2011/08/21
2011/08/22
2011/08/23
2011/08/24
Browse by creation date
Browse by origin
Embassy Athens
Embassy Asuncion
Embassy Astana
Embassy Asmara
Embassy Ashgabat
Embassy Apia
Embassy Antananarivo
Embassy Ankara
Embassy Amman
Embassy Algiers
Embassy Addis Ababa
Embassy Accra
Embassy Abuja
Embassy Abu Dhabi
Embassy Abidjan
Consulate Auckland
Consulate Amsterdam
Consulate Alexandria
Consulate Adana
American Institute Taiwan, Taipei
Embasy Bonn
Embassy Bujumbura
Embassy Buenos Aires
Embassy Budapest
Embassy Bucharest
Embassy Brussels
Embassy Bridgetown
Embassy Brazzaville
Embassy Bratislava
Embassy Brasilia
Embassy Bogota
Embassy Bishkek
Embassy Bern
Embassy Berlin
Embassy Belmopan
Embassy Belgrade
Embassy Beirut
Embassy Beijing
Embassy Banjul
Embassy Bangui
Embassy Bangkok
Embassy Bandar Seri Begawan
Embassy Bamako
Embassy Baku
Embassy Baghdad
Consulate Belfast
Consulate Barcelona
Embassy Cotonou
Embassy Copenhagen
Embassy Conakry
Embassy Colombo
Embassy Chisinau
Embassy Caracas
Embassy Canberra
Embassy Cairo
Consulate Curacao
Consulate Ciudad Juarez
Consulate Chiang Mai
Consulate Chennai
Consulate Chengdu
Consulate Casablanca
Consulate Cape Town
Consulate Calgary
Embassy Dushanbe
Embassy Dublin
Embassy Doha
Embassy Djibouti
Embassy Dili
Embassy Dhaka
Embassy Dar Es Salaam
Embassy Damascus
Embassy Dakar
DIR FSINFATC
Consulate Dusseldorf
Consulate Durban
Consulate Dubai
Consulate Dhahran
Embassy Guatemala
Embassy Grenada
Embassy Georgetown
Embassy Gaborone
Consulate Guayaquil
Consulate Guangzhou
Consulate Guadalajara
Embassy Helsinki
Embassy Harare
Embassy Hanoi
Consulate Hong Kong
Consulate Ho Chi Minh City
Consulate Hermosillo
Consulate Hamilton
Consulate Hamburg
Consulate Halifax
Embassy Kyiv
Embassy Kuwait
Embassy Kuala Lumpur
Embassy Kolonia
Embassy Kinshasa
Embassy Kingston
Embassy Kigali
Embassy Khartoum
Embassy Kathmandu
Embassy Kampala
Embassy Kabul
Consulate Krakow
Consulate Kolkata
Consulate Karachi
Embassy Luxembourg
Embassy Lusaka
Embassy Luanda
Embassy London
Embassy Lome
Embassy Ljubljana
Embassy Lisbon
Embassy Lima
Embassy Lilongwe
Embassy Libreville
Embassy La Paz
Consulate Leipzig
Consulate Lahore
Consulate Lagos
Mission USOSCE
Mission USNATO
Mission UNESCO
Mission Geneva
Embassy Muscat
Embassy Moscow
Embassy Montevideo
Embassy Monrovia
Embassy Mogadishu
Embassy Minsk
Embassy Mexico
Embassy Mbabane
Embassy Maseru
Embassy Maputo
Embassy Manila
Embassy Manama
Embassy Managua
Embassy Malabo
Embassy Madrid
Consulate Munich
Consulate Mumbai
Consulate Montreal
Consulate Monterrey
Consulate Milan
Consulate Merida
Consulate Melbourne
Consulate Matamoros
Consulate Marseille
Embassy Nouakchott
Embassy Nicosia
Embassy Niamey
Embassy New Delhi
Embassy Ndjamena
Embassy Nassau
Embassy Nairobi
Consulate Nuevo Laredo
Consulate Naples
Consulate Naha
Consulate Nagoya
Embassy Pristina
Embassy Pretoria
Embassy Praia
Embassy Prague
Embassy Port Of Spain
Embassy Port Moresby
Embassy Port Louis
Embassy Port Au Prince
Embassy Podgorica
Embassy Phnom Penh
Embassy Paris
Embassy Paramaribo
Embassy Panama
Consulate Peshawar
REO Hillah
REO Basrah
Embassy Rome
Embassy Riyadh
Embassy Riga
Embassy Reykjavik
Embassy Rangoon
Embassy Rabat
Consulate Rio De Janeiro
Consulate Recife
Secretary of State
Embassy Suva
Embassy Stockholm
Embassy Sofia
Embassy Skopje
Embassy Singapore
Embassy Seoul
Embassy Sarajevo
Embassy Santo Domingo
Embassy Santiago
Embassy Sanaa
Embassy San Salvador
Embassy San Jose
Consulate Surabaya
Consulate Strasbourg
Consulate St Petersburg
Consulate Shenyang
Consulate Shanghai
Consulate Sapporo
Consulate Sao Paulo
Embassy Tunis
Embassy Tripoli
Embassy Tokyo
Embassy Tirana
Embassy The Hague
Embassy Tel Aviv
Embassy Tehran
Embassy Tegucigalpa
Embassy Tbilisi
Embassy Tashkent
Embassy Tallinn
Consulate Toronto
Consulate Tijuana
Consulate Thessaloniki
USUN New York
USMISSION USTR GENEVA
USEU Brussels
US Office Almaty
US Mission Geneva
US Mission CD Geneva
US Interests Section Havana
US Delegation, Secretary
UNVIE
UN Rome
Embassy Ulaanbaatar
Embassy Vilnius
Embassy Vientiane
Embassy Vienna
Embassy Vatican
Embassy Valletta
Consulate Vladivostok
Consulate Vancouver
Browse by tag
AMGT
ASEC
AEMR
AR
APECO
AU
AORC
ADANA
AJ
AF
AFIN
AMED
AS
AM
ABLD
AFFAIRS
AMB
APER
ACOA
AND
AA
AE
AADP
AID
AO
AL
AG
AORD
ADM
AINF
AINT
ASEAN
AORG
ABT
APEC
AY
ASUP
ARF
AGOA
AVIAN
ATRN
ANET
AGIT
ASECVE
ABUD
AODE
ALOW
ADB
AN
ADPM
ASPA
ARABL
AFSN
AZ
AC
AIAG
AFSI
ASCE
ASIG
ACABQ
ADIP
AFGHANISTAN
AROC
ADCO
ACOTA
ANARCHISTS
AMEDCASCKFLO
AK
ARABBL
ASCH
ANTITERRORISM
AGRICULTURE
AOCR
ARR
ASSEMBLY
AORCYM
AFPK
ACKM
AGMT
AEC
APRC
AIN
AFPREL
ASFC
ASECTH
AFSA
AINR
AOPC
AFAF
AFARI
AX
ASECAF
ASECAFIN
AT
AFZAL
APCS
AGAO
AIT
ARCH
AEMRASECCASCKFLOMARRPRELPINRAMGTJMXL
AMEX
ARM
AQ
ATFN
AMBASSADOR
AORCD
AVIATION
ARAS
AINFCY
ACBAQ
AOPR
AREP
AOIC
ASEX
ASEK
AER
AGR
AMCT
AVERY
APR
AEMRS
AFU
AMG
ATPDEA
ASECKFRDCVISKIRFPHUMSMIGEG
AORL
ACS
AMCHAMS
AECL
AUC
ACAO
BA
BR
BB
BG
BEXP
BY
BRUSSELS
BU
BD
BTIO
BK
BL
BE
BMGT
BO
BM
BX
BN
BWC
BBSR
BTT
BC
BH
BILAT
BUSH
BHUM
BT
BTC
BMENA
BOND
BAIO
BP
BF
BRPA
BURNS
BUT
BBG
BCW
BOEHNER
BOL
BASHAR
BIDEN
BFIN
BZ
BEXPC
BTIU
CPAS
CA
CASC
CS
CBW
CIDA
CO
CODEL
CI
CROS
CU
CH
CWC
CMGT
CVIS
CDG
CTR
CG
CF
CHIEF
CJAN
CBSA
CE
CY
CB
CW
CM
CHR
CD
COE
CV
COUNTER
CT
CN
CPUOS
CTERR
CVR
CVPR
CDC
COUNTRY
CLEARANCE
CONS
COM
CACS
CR
CONTROLS
CAN
CACM
COMMERCE
CAMBODIA
CFIS
COUNTERTERRORISM
CITES
CONDOLEEZZA
CZ
CTBT
CEN
CLINTON
CFED
CARC
CTM
CARICOM
CSW
CICTE
CYPRUS
CBE
CMGMT
CARSON
CWCM
CIVS
COUNTRYCLEARANCE
CENTCOM
CAPC
COPUOS
CKGR
CITEL
CQ
CITT
CIC
CARIB
CVIC
CAFTA
CVISU
CDB
CEDAW
CNC
CJUS
COMMAND
CENTER
COL
CAJC
CONSULAR
CLMT
CBC
CIA
CNARC
CIS
CEUDA
CHINA
CAC
CL
DR
DJ
DEMOCRATIC
DEMARCHE
DOMESTIC
DISENGAGEMENT
DB
DA
DHS
DAO
DCM
DAVID
DO
DEAX
DEFENSE
DEA
DTRO
DPRK
DOC
DTRA
DK
DAC
DOD
DRL
DRC
DCG
DE
DOT
DEPT
DOE
DS
DKEM
ECON
ETTC
EFIS
ETRD
EC
EMIN
EAGR
EAID
EFIN
EUN
ECIN
EG
EWWT
EINV
ENRG
ELAB
EPET
EIND
EN
EAIR
EUMEM
ECPS
ES
EI
ELTN
ET
EZ
EU
ER
EINT
ENGR
ECONOMIC
ENIV
EFTA
ETRN
EMS
EUREM
EPA
ESTH
EEB
EET
ENV
EAG
EXIM
ECTRD
ELNT
ENVIRONMENT
ECA
EAP
EINDIR
ETR
ECONOMY
ETRC
ELECTIONS
EICN
EXPORT
EARG
EGHG
EID
ETRO
EINF
EAIDHO
ECIP
EENV
EURM
EPEC
ERNG
ENERG
EIAD
EXBS
ED
EREL
ELAM
EK
EWT
ENGRD
EDEV
ECE
ENGY
EXIMOPIC
ETRDEC
ECCT
EUR
ENRGPARMOTRASENVKGHGPGOVECONTSPLEAID
EFI
ECOSOC
EXTERNAL
ESCAP
ETCC
EENG
ERA
ENRD
ECLAC
ETRAD
EBRD
ENVR
ECONENRG
ELTNSNAR
ELAP
EPIT
EDUC
EAIDXMXAXBXFFR
EETC
EIVN
EDRC
EGOV
ETRA
EAIDRW
ETRDEINVECINPGOVCS
ESA
ETRDGK
ENVI
ELN
EPRT
EPTED
ERTD
EUM
EAIDS
EFINECONEAIDUNGAGM
EDU
EV
EAIDAF
EDA
EPREL
EINVEFIN
EAGER
ETMIN
EUCOM
ECCP
EIDN
EINVKSCA
ENNP
EFINECONCS
ETC
EAIRASECCASCID
EINN
ETRP
ECONOMICS
ENERGY
EIAR
EINDETRD
ECONEFIN
EURN
ETRDEINVTINTCS
EFIM
ETIO
EATO
EIPR
EINVETC
ETTD
ETDR
EIQ
ECONCS
ENRGIZ
EAIG
ENTG
EUC
ERD
EINVECONSENVCSJA
EEPET
EUNCH
ESENV
ECINECONCS
ETRDECONWTOCS
ECUN
FR
FI
FOREIGN
FARM
FIR
FAO
FK
FARC
FAS
FJ
FREEDOM
FAC
FINANCE
FBI
FTAA
FM
FCS
FAA
FORCE
FDA
FTA
FT
FCSC
FMGT
FINR
FIN
FDIC
FOR
FOI
FO
FMLN
FISO
GM
GERARD
GT
GA
GG
GR
GTIP
GH
GZ
GE
GB
GY
GAZA
GJ
GEORGE
GOI
GCC
GMUS
GI
GLOBAL
GV
GC
GL
GOV
GKGIC
GF
GWI
GIPNC
GUTIERREZ
GTMO
GANGS
GAERC
GUILLERMO
GASPAR
HR
HA
HYMPSK
HO
HK
HUMAN
HU
HN
HHS
HURI
HUD
HUMRIT
HUMANITARIAN
HUMANR
HL
HSTC
HILLARY
HCOPIL
HADLEY
HOURANI
HI
HUM
HEBRON
HUMOR
IZ
IN
IAEA
IS
IMO
ILO
IR
IC
IT
ITU
ID
IV
IMF
IBRD
IWC
ICAO
ICRC
INF
IO
IPR
ISO
IK
ISRAELI
IQ
ICES
IDB
INFLUENZA
IRAQI
ISCON
IGAD
IRAN
ITALY
IRAQ
ICTY
ICTR
ITPGOV
ITALIAN
IQNV
IADB
INTERNAL
INMARSAT
IRDB
ILC
INCB
INRB
ICJ
ISRAEL
INR
IEA
ISPA
ICCAT
IOM
ITRD
IHO
IL
IFAD
ITRA
IDLI
ISCA
INL
INRA
INTELSAT
ISAF
ISPL
IRS
IEF
ITER
INDO
IIP
IND
IEFIN
IACI
IAHRC
INNP
IA
INTERPOL
IFIN
ISSUES
IZPREL
IRAJ
IF
ITPHUM
ITA
IP
IRPE
IDA
ISLAMISTS
ITF
INRO
IBET
IDP
IRC
KMDR
KPAO
KOMC
KNNP
KFLO
KDEM
KSUM
KIPR
KFLU
KE
KCRM
KJUS
KAWC
KZ
KSCA
KDRG
KCOR
KGHG
KPAL
KTIP
KMCA
KCRS
KPKO
KOLY
KRVC
KVPR
KG
KWBG
KTER
KS
KN
KSPR
KWMN
KV
KTFN
KFRD
KU
KSTC
KSTH
KISL
KGIC
KSEP
KFIN
KTEX
KTIA
KUNR
KCMR
KCIP
KMOC
KTDB
KBIO
KBCT
KMPI
KSAF
KACT
KFEM
KPRV
KPWR
KIRC
KCFE
KRIM
KHIV
KHLS
KVIR
KNNNP
KCEM
KLIG
KIRF
KNUP
KSAC
KNUC
KPGOV
KTDD
KIDE
KOMS
KLFU
KNNC
KMFO
KSEO
KJRE
KJUST
KMRS
KSRE
KGIT
KPIR
KPOA
KUWAIT
KIVP
KICC
KSCS
KPOL
KSEAO
KRCM
KSCI
KNAP
KGLB
KICA
KCUL
KPRM
KFSC
KQ
KPOP
KPFO
KPALAOIS
KREC
KBWG
KR
KTTB
KNAR
KCOM
KESS
KINR
KOCI
KWN
KCSY
KREL
KTBT
KFTN
KW
KRFD
KFLOA
KHDP
KNEP
KIND
KHUM
KSKN
KOMO
KDRL
KTFIN
KSOC
KPO
KGIV
KSTCPL
KSI
KPRP
KFPC
KNNB
KNDP
KICCPUR
KFRDCVISCMGTCASCKOCIASECPHUMSMIGEG
KDMR
KFCE
KIMMITT
KMCC
KMNP
KSEC
KOMCSG
KGCC
KRAD
KCRP
KAUST
KWAWC
KCHG
KRDP
KPAS
KTIAPARM
KPAOPREL
KWGB
KIRP
KMIG
KLAB
KSEI
KHSA
KNPP
KPAONZ
KWWW
KGHA
KY
KCRIM
KCRCM
KGCN
KPLS
KIIP
KPAOY
KTRD
KTAO
KJU
KBTS
KWAC
KFIU
KNNO
KPAI
KILS
KPA
KRCS
KWBGSY
KNPPIS
KNNPMNUC
KNPT
KERG
KLTN
KPREL
KTLA
KO
KAWK
KVRP
KAID
KX
KENV
KWCI
KNPR
KCFC
KNEI
KFTFN
KTFM
KCERS
KDEMAF
KMEPI
KEMS
KBTR
KEDU
KIRL
KNNR
KMPT
KPDD
KPIN
KDEV
KFRP
KTBD
KMSG
KWWMN
KWBC
KA
KOM
KWNM
KFRDKIRFCVISCMGTKOCIASECPHUMSMIGEG
KRGY
KNNF
KICR
KIFR
KWMNCS
KPAK
KDDG
KCGC
KID
KNSD
KMPF
KWMM
MARR
MX
MASS
MOPS
MNUC
MCAP
MTCRE
MRCRE
MTRE
MASC
MY
MK
MG
MU
MILI
MO
MZ
MEPP
MCC
MEDIA
MOPPS
MI
MAS
MW
MP
MEPN
MV
MD
MR
MC
MCA
MT
MIL
MARITIME
MOPSGRPARM
MAAR
MOOPS
ML
MA
MN
MNUCPTEREZ
MTCR
MUNC
MPOS
MONUC
MGMT
MURRAY
MACP
MINUSTAH
MCCONNELL
MGT
MNUR
MF
MEPI
MOHAMMAD
MAR
MAPP
MNU
MFA
MTS
MLS
MEETINGS
MERCOSUR
MED
MNVC
MIK
MBM
MILITARY
MAPS
MARAD
MDC
MACEDONIA
MASSMNUC
MUCN
MQADHAFI
MPS
NZ
NATO
NI
NO
NU
NG
NL
NPT
NS
NA
NP
NASA
NSF
NEA
NANCY
NSG
NRR
NATIONAL
NMNUC
NC
NSC
NAS
NARC
NELSON
NATEU
NDP
NIH
NK
NIPP
NR
NERG
NSSP
NE
NTDB
NT
NEGROPONTE
NGO
NATOIRAQ
NAR
NZUS
NCCC
NH
NAFTA
NEW
NRG
NUIN
NOVO
NATOPREL
NV
NICHOLAS
NPA
NSFO
NW
NORAD
NPG
NOAA
OPRC
OPDC
OTRA
OECD
OVIP
OREP
ODC
OIIP
OAS
OSCE
OPIC
OMS
OFDP
OFDA
OEXC
OPCW
OIE
OSCI
OM
OPAD
ODPC
OIC
ODIP
OPPI
ORA
OCEA
OREG
OMIG
OFFICIALS
OSAC
OEXP
OPEC
OFPD
OAU
OCII
OIL
OVIPPRELUNGANU
OSHA
OPCD
OPCR
OF
OFDPQIS
OSIC
OHUM
OTR
OBSP
OGAC
OESC
OVP
ON
OES
OTAR
OCS
PREL
PGOV
PARM
PINR
PHUM
PM
PREF
PTER
PK
PINS
PBIO
PHSA
PE
PBTS
PA
PL
POL
PAK
POV
POLITICS
POLICY
PO
PRELTBIOBA
PKO
PIN
PNAT
PU
PGOVPREL
PALESTINIAN
PTERPGOV
PELOSI
PAS
PP
PTEL
PROP
PRELAF
PRHUM
PRE
PUNE
PIRF
PVOV
PROG
PERSONS
PROV
PKK
PRGOV
PH
PLAB
PDEM
PCI
PRL
PRM
PINSO
PERM
PETR
PPAO
PERL
PBS
PETERS
PRELBR
PCON
POLITICAL
PMIL
POLM
PKPA
PNUM
PLO
PTERM
PJUS
PARMP
PNIR
PHUMKPAL
PG
PREZ
PGIC
PAO
PROTECTION
PRELPK
PGOVENRG
PATTY
PSOC
PARTIES
PGOVEAIDUKNOSWGMHUCANLLHFRSPITNZ
PMIG
PAIGH
PARK
PETER
PHUS
PKPO
PGOVECON
POUS
PMAR
PWBG
PAR
PGOVGM
PHUH
PTE
PY
POLUN
PDOV
PGOVSOCI
PGOVPM
PRELEVU
PGOR
PBTSRU
PHUMA
PHUMR
PPD
PGV
PRAM
PARMS
PINL
PSI
PKPAL
PPA
PTERE
PGOF
PINO
PREO
PHAS
PAC
PRESL
PORG
PS
PGVO
PKFK
PSOE
PEPR
PINT
PRELP
PREFA
PNG
PTBS
PFOR
PGOVLO
PHUMBA
PREK
PHJM
POLINT
PGOVE
PHALANAGE
PARTY
PECON
PEACE
PROCESS
PLN
PEDRO
PF
PGPV
PCUL
PGGV
PSA
PGOVSMIGKCRMKWMNPHUMCVISKFRDCA
PGIV
PHUMPREL
POGOV
PEL
PBT
PAMQ
PINF
PSEPC
POSTS
PAHO
PHUMPGOV
PGOC
PNR
RS
RP
RU
RW
RFE
RCMP
RIGHTSPOLMIL
REFORM
RO
ROW
ROBERT
REACTION
REPORT
REGION
RELATIONS
RAY
ROBERTG
RIGHTS
RM
RATIFICATION
RREL
RBI
RICE
ROOD
REL
RODHAM
RGY
RUEHZO
RELIGIOUS
RELFREE
RUEUN
RELAM
RSP
RF
REO
REGIONAL
RUPREL
RI
REMON
RPEL
RSO
SCUL
SENV
SOCI
SZ
SNAR
SO
SP
SU
SY
SI
SMIG
SYR
SA
SW
SF
SR
SYRIA
SNARM
START
SPECIALIST
SG
SNIG
SCI
SGWI
SE
SIPDIS
SANC
SELAB
SN
SETTLEMENTS
SCIENCE
SENVENV
SENS
SPCE
SPAS
SECURITY
SENC
SOCIETY
SOSI
SENVEAGREAIDTBIOECONSOCIXR
SEN
SPECI
ST
SL
SENVCASCEAIDID
SC
SECRETARY
STR
SNA
SOCIS
SADC
SEP
SK
SHUM
SYAI
SMIL
STEPHEN
SNRV
SKCA
SENSITIVE
SECI
SCUD
SCRM
SGNV
SECTOR
SAARC
SENVSXE
SWMN
STEINBERG
SOPN
SOCR
SCRS
SWE
SARS
SNARIZ
SUDAN
SENVQGR
SAN
SM
SFNV
SSA
SPCVIS
SOFA
SCULKPAOECONTU
SENVKGHG
SHI
SEVN
SH
SNARCS
SNARN
SIPRS
TBIO
TW
TRGY
TSPA
TU
TPHY
TI
TX
TH
TIP
TSPL
TNGD
TZ
TS
TC
TK
TURKEY
TERRORISM
TPSL
TINT
TRSY
TERFIN
TPP
TT
TECHNOLOGY
TE
TAGS
TRAFFICKING
TJ
TN
TO
TD
TP
TREATY
TR
TA
TIO
TECH
TF
TRAD
TNDG
TWI
TPSA
TWL
TAUSCHER
TRBY
TL
TV
THPY
TSPAM
TREL
TRT
TNAR
TFIN
TWCH
THOMMA
THOMAS
TERROR
TRY
TBID
UK
UNESCO
UNSC
UNGA
UN
US
UZ
USEU
UG
UP
UNAUS
UNMIK
USTR
UY
USUN
UNEP
UNDC
UV
UNPUOS
UNSCR
USAID
UNODC
UNRCR
UNHCR
UNDP
UNCRIME
UA
UNHRC
UNRWA
UNO
UNCND
UNCHR
USAU
UNICEF
USPS
UNOMIG
UNESCOSCULPRELPHUMKPALCUIRXFVEKV
UR
UNFICYP
UNCITRAL
UNAMA
UNVIE
USTDA
USNC
UNCSD
USCC
UNEF
UNGAPL
USSC
UNMIC
UNTAC
UNCLASSIFIED
USDA
UNCTAD
USGS
UNFPA
UNSE
USOAS
UE
UAE
UNCHS
UNDESCO
UNC
UNSCS
UKXG
UNGACG
UNHR
UNBRO
UNCHC
UNFCYP
UNIDROIT
WHTI
WIPO
WTRO
WHO
WTO
WMO
WFP
WEET
WS
WE
WA
WHA
WBG
WILLIAM
WI
WSIS
WCL
WEBZ
WZ
WW
WWBG
WMD
WWT
WMN
WWARD
WITH
WTRQ
WCO
WEU
WB
WBEG
Browse by classification
Community resources
courage is contagious
Viewing cable 04ANKARA1157, Pharmaceuticals Update: Multinationals
If you are new to these pages, please read an introduction on the structure of a cable as well as how to discuss them with others. See also the FAQs
Understanding cables
Every cable message consists of three parts:
- The top box shows each cables unique reference number, when and by whom it originally was sent, and what its initial classification was.
- The middle box contains the header information that is associated with the cable. It includes information about the receiver(s) as well as a general subject.
- The bottom box presents the body of the cable. The opening can contain a more specific subject, references to other cables (browse by origin to find them) or additional comment. This is followed by the main contents of the cable: a summary, a collection of specific topics and a comment section.
Discussing cables
If you find meaningful or important information in a cable, please link directly to its unique reference number. Linking to a specific paragraph in the body of a cable is also possible by copying the appropriate link (to be found at theparagraph symbol). Please mark messages for social networking services like Twitter with the hash tags #cablegate and a hash containing the reference ID e.g. #04ANKARA1157.
Reference ID | Created | Released | Classification | Origin |
---|---|---|---|---|
04ANKARA1157 | 2004-02-27 11:34 | 2011-08-24 01:00 | UNCLASSIFIED//FOR OFFICIAL USE ONLY | Embassy Ankara |
This record is a partial extract of the original cable. The full text of the original cable is not available.
UNCLAS SECTION 01 OF 05 ANKARA 001157
SIPDIS
DEPT FOR EB/TPP/MTA/IPC - SWILSON/JURBAN AND EUR/SE
DEPT PASS USTR FOR LERRION/BPECK
DEPT PASS LIBRARY OF CONGRESS
DEPT PASS USPTO FOR ELAINE WU
USDOC FOR ITA/MAC/DDEFALCO
SENSITIVE
E.O. 12958: N/A
TAGS: ETRD KIPR TU
SUBJECT: Pharmaceuticals Update: Multinationals
Threatened by New Pricing Decree
Ref: Ankara 977 and previous
Summary
-------
¶1. (SBU) U.S. companies have complained that a new GOT
pricing caps threaten the commercial viability of many
of their product lines, and could lead them to delay or
suspend the launch of new pharmaceuticals in Turkey. In
a letter to USTR, the Foreign Trade Undersecretary
maintains that the GOT views data exclusivity as an EU
Customs Union obligation rather than a WTO TRIPS
requirement, and that this policy will be introduced
with an unspecified transition period. The GOT's
Council of State rendered a decision limiting the
application of "cheapest generic" reimbursement policy
in the state pension fund. Embassy requests guidance on
the pricing decree, and urges Washington agencies to
pursue sustained engagement with the GOT on intellectual
property and other WTO issues affecting the
pharmaceuticals sector. End Summary.
New Price System A Blow to Research-Based Firms
--------------------------------------------- --
¶2. (U) At a February 20 briefing for the Ambassador,
U.S. companies expressed serious concern with a February
14 pricing decree. The decree, which is already in
force, limits pharmaceuticals prices in Turkey to a
maximum of 90 percent of the average of the lowest two
prices prevailing in a group of five European countries.
While the measure does not appear to address any
intellectual property issues, it may contain WTO-
inconsistent provisions allowing higher prices for
domestically-produced generic drugs, and does not set
objective pricing criteria or remedy mechanisms for
companies applying under the decree (reproduced in para
9).
¶3. (U) Research-based companies had pressed for changes
to the previous pricing system, which applied
discriminatory price limits on imported pharmaceuticals,
and had even suggested some forms of reference pricing.
While the new system eliminates many of those
provisions, research-based companies have told us that
the new system will render sale of some medicines
unprofitable, and could lead to delay or suspension in
the launch of new molecules in Turkey. AIFD, the
Turkish research-based pharmaceuticals association, has
written to the Prime Minister to register its concerns
with the decree.
¶4. (SBU) Econoff raised U.S. company concerns with
Hayriye Mihcak, the Health Ministry's Director General
for Pharmaceuticals, Dilek Emil, the Treasury
Undersecretariat's Deputy Director General for Foreign
Investment, and Husnu Dilemre, Foreign Trade's Deputy
Director General for Multilateral Agreements. All
expressed some surprise that research-based companies
did not consider the decree an improvement over the
previous pricing system. Foreign Trade told us that the
Turkish decree was modeled on Portugese and Spanish drug
pricing systems.
Data Exclusivity
----------------
¶5. (SBU) The GOT has not made an announcement on data
exclusivity, though Mihcak told us that the Government
planned to make an announcement on this by the end of
March. Dilemre also said that a decision on data
exclusivity would be announced soon, but emphasized that
Turkey viewed this as an EU Customs Union obligation
rather than a WTO TRIPS requirement. In a February 11
letter to A/USTR Novelli (reproduced in para 10),
Foreign Trade Undersecretary Tuncer Kayalar also made
these points, but argued that Turkey would need a
transition period for implementation.
Legal Challenge on Reimbursement Policy
---------------------------------------
¶6. (U) In January 2004, the Council of State (Danistay)
issued a ruling restricting application of the "cheapest
generic" pharmaceuticals reimbursement policy for the
GOT's pension fund. The decision, a preliminary
injunction, calls for the GOT to stop implementation,
within 30 days, of "cheapest generic" reference pricing.
However, industry sources have said that the injunction
is likely to be overturned as the case moves through the
courts. The Danistay also limited reimbursement of
generics to those which the GOT has certified as
"bioequivalent" with the brand name molecule. While
research-based companies have welcomed the decision, the
impact will be limited: industry sources relate that
there is now a bioequivalent generic for most original
drugs.
Comment/Action Request
----------------------
¶7. (SBU) Research-based industry is alarmed by the new
pricing decree, though its concerns seem to lie more
with the pricing formula for brand name drugs than with
the parts of the decree (generic pricing, transparency)
that could be WTO-inconsistent. Embassy requests
Washington agencies' guidance on whether to advocate for
change in the pricing formula.
¶8. (SBU) As noted reftel, elevating Turkey in the
Special 301 Watch List system, combined with sustained
Washington engagement, is our best hope for prodding the
GOT to action on data exclusivity and WTO-inconsistent
practices. We understand that Commerce A/S Lash and
Senator Lugar plan to write to top GOT officials on
pharmaceuticals issues. Embassy continues to recommend
that Washington agencies also consider dispatching an
interagency IPR delegation to Ankara, and sending
additional high-level correspondence on these issues,
and particularly to rebut the GOT's position that the
TRIPS Agreement does not require data exclusivity.
¶9. (U) Begin Text - AIFD Translation of GOT Pricing
Decree:
Decision No: 2004/6781
It has been decided to enforce the attached "Decision
Regarding the Pricing of Medicinal Product for Human
Use" upon the letter dated 21/1/2004 and 003149 of the
Ministry of Health, by the Council of Ministers on
6/2/2004.
Decision Regarding the Pricing of Medicinal Products for
Human Use
Article 1 - In accordance with "the Law no. 1262 on
Pharmaceutical and Medicinal Products" and "the
Fundamental Law no. 3359 on Healthcare Services", the
Ministry of Health (the Ministry) shall determine the
maximum prices by adopting the necessary measures that
will be taken to ensure the affordability of medicinal
products for human use (products). Companies may
request prices below the maximum price. The price
approved by the Ministry of Health shall be in effect as
of the date of its approval.
Article 2 - The Ministry of Finance shall be authorized
to investigate the suitability of these prices to the
principles set forth in this Decision.
Article 3- The maximum price of original products,
excluding VAT, shall be determined as follows: 2
reference countries with the cheapest prices of the
product for which a price is to be determined in Turkey
shall be selected out of 5 countries, namely France,
Italy, Spain, Portugal and Greece in the year 2004 and
to be deemed as suitable among the European Union (EU)
countries by the Ministry; the retailer sale price of
the product shall be determined by taking as basis
maximum 90 percent of the average ex-factory price
(sales price to the wholesalers calculated by deducting
pharmacy and wholesaler profits from the retailer sale
price) of these 2 reference countries and by adding the
profit rates of wholesalers and pharmacies to be
calculated in accordance with article 10. Should the ex-
factory price in the country from where the product is
imported be lower than the determined reference price,
the profit rates of wholesalers and pharmacies shall be
added to the price in the country from where it is
imported.
Article 4 - The retailer sales price of generic
products, excluding VAT, shall be determined by taking
as basis maximum 70 percent of the average of the ex-
factory sales price of the original drugs of these
products, calculated in accordance with article 3 and
adding the profit rates of wholesalers and pharmacies.
Yet, the maximum rate may be increased to 80 percent in
case it is documented that locally manufactured raw
materials have been utilized as the active ingredient of
the drug in the production of generic products. In case
the ex-factory sales price in the country from where the
product is imported, results to be lower than the price
determined for the EU countries, the profit rates of the
wholesaler and pharmacies shall be added to the price in
the pertinent country.
Article 5 - The price of the products not marketed
outside Turkey and the products not marketed by the EU
countries shall be determined by taking into
consideration the principles and the cost factors set
forth in articles 3 and 4, provided it does not surpass
the price of similar products.
Article 6 - The ex-factory price of the products packed
for hospitals shall be determined by taking into
consideration the principles and the cost factors set
forth in articles 3 and 4, provided it remains at least
10percent below the unit prices of the original
products.
Article 7 - A "Price Evaluation Commission" shall be
established and convene on a quarterly basis upon the
participation of the representatives of the Ministry of
Finance, the State Planning Organization and the Turkish
Treasury under the coordination of the Ministry of
Health, in order to submit proposals to the Ministry of
Health for the increase, decrease, or freezing of the
price of medicinal products. In case of a change of more
than 5percent in the foreign exchange rate within a
minimum period of 30 days, the Price Evaluation
Commission shall convene on an extraordinary basis, upon
the invitation of the Ministry of Health to re-evaluate
the prices of products. The secretarial services of the
commission in question shall be executed by the Ministry
of Health.
A "Reimbursement Commission" shall be established and
convene once every 6 months upon the participation of
the representatives of the Ministry of Health, the State
Planning Organization and the Turkish Treasury, the
Social Insurance Institution, Emekli Sandygy and Bad-Kur
and upon consulting the views of civil society
organizations, under the coordination of the Ministry of
Health, in order to submit proposals to the pertinent
ministries. The secretarial services of the commission
in question shall be executed by the Ministry of Health.
Article 8 - Product manufacturers and importers shall
be obligated to document that their products are
original or generic. Manufacturers and importers shall
be obligated to submit to the Ministry the ex-factory
prices in the reference countries together with their
requests for obtaining, increasing or decreasing a
price. The TL equivalent of the prices determined shall
be calculated upon the foreign exchange sales rate of
the Central Bank of the Turkish Republic. The price
which is deemed suitable shall be approved by the
Ministry within 10 working days. The justification for a
price which is not deemed suitable shall be communicated
by the Ministry to the concerned company within 10
working days. The pricing transaction shall be executed
within 90 working days upon the submission of the valid
documentation by the concerned company. This period may
be extended by 60 working days in case of accumulation
of applications and in periods of heavy workload. In
case of failure of the concerned companies to submit
their valid documents, the price determined by the
Ministry shall be retained valid.
Article 9 - In case of a decrease of 5percent or more in
the price of the original product in the reference
countries, the company manufacturing or importing the
product shall be obligated to apply to the Ministry
within 30 days to obtain a new price. A second degree
withdrawal transaction shall be implemented on the
products for it is determined by the Ministry that no
such notification has been made and the registration
shall be suspended for a period three times longer than
the period in which no notification has been made,
including 30 days. The suspension transaction shall be
annulled by issuing the new price at the end of this
period.
Article 10- The wholesaler and pharmacy profit rates to
be implemented when determining the retailer sales
price of products in accordance with article 3 and 4,
shall be determined in segments as follows, for both
imported and local products:
Out of the sales price to wholesalers/Wholesaler
(Percent)/Pharmacy (Percent):
Part up to/including 10 million TL: 9, 25
Part between 10 - 50 million TL: 8, 24
Part between 50 - 100 million TL: 7, 23
Part between 100 - 200 million TL: 4, 16
Part above 200 million TL: 2, 10
The Ministry of Health shall be authorized to review
these rates by taking into consideration the annual
wholesale price index of chemical products of the State
Statistics Institute of the former year and the
allocation of the total sales of medicinal products in
the last 3 years.
Article 11 - Product manufacturers and importers are
obligated to adhere to the principles set forth in this
Decision. Legal action within the pertinent
legislation shall be taken against those in violation
of these principles.
Article 12 - The Ministry shall be authorized to issue
notifications with regard to the implementation of this
Decision.
Article 13 - The Council of Ministers Decision dated
6/2/2002, with no. 2002/4331 has been revoked.
Temporary Article l- As of the publication date of this
Decision, the prices of registered products shall be re-
determined in accordance with the principles set forth
in this Decision. The concerned companies shall apply to
the Ministry upon having compiled the necessary
documents in accordance with this Decision, within 45
days as of the publication date of the Decision, in
order to establish a basis for the determination of the
new prices. The registrations of the products for which
no application is submitted within this period shall be
suspended until the application date. The sales prices
excluding VAT, to be determined in accordance with this
article, shall not surpass the price in TL, excluding
VAT, on the date of this Decision for local products,
and the amount in TL, excluding VAT, corresponding to
the foreign exchange sales rate of the Central Bank of
the Turkish Republic, on the application date for the
product for imported products.
Temporary Article 2- The prices of imported products
shall be re-determined ex-officio by the Ministry over
the foreign exchange sales rate of the Central Bank of
the Turkish Republic on the publication date of this
Decision. The new prices shall be retained valid as of
the approval date.
Article 14- This Decision shall be enforced as of its
publication date.
Article 15- This Decision shall be executed by the
Council of Ministers.
End Text - AIFD Translation of GOT Pricing Decree.
¶10. (U) Begin Text - Foreign Trade U/S - USTR Letter
February 11, 2004
Ms. Catherine A. Novelli
Assistant US-Trade Representative for
Europe and the Mediterranean
Dear Ms. Novelli,
I would like to thank you for your letter dated January
14, 2004 which has provided me with the opportunity to
clarify the misconception about the compliance of
Turkey's IPR legislation with the TRIPS Agreement.
As you will recall, the WTO Members unanimously
confirmed the consistency of Turkey's IPR legislation
and implementations with the TRIPS Agreement at the
TRIPS Council's meeting in Geneva on November 30, 2000.
Besides, as referred in your letter, our authorities are
working on a plan to introduce and implement rules and
regulations regarding data exclusivity in
pharmaceuticals in line with our commitments arising
from the Customs Union with the EU.
As you may appreciate, this plan will not only have
negative impacts on the consumers and the current public
health policies but on the generic industry as well.
Therefore, the transition period turns out to be a
necessity to offset to a certain extent the economic and
social pressures and to avoid any further economic
damages that would be recovered at a higher cost
otherwise.
On the other hand, I would like to note that my
colleagues are doing their best to figure out an option
that keeps the transition period as short as possible.
At this point, supportive approaches from our trading
partners will certainly contribute to the early
conclusion of their studies.
Expressing my best wishes and highest regards to you, I
remain,
Sincerely Yours,
Tuncer Kayalar
Undersecretary
End Text Foreign Trade/USTR Letter.
Edelman